CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 45 filers reported holding CYTOSORBENTS CORP in Q4 2017. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $115,000 | – | 17,689 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skylands Capital, LLC | 1,126,300 | $8,706,000 | 1.93% |
| Sargent Investment Group, LLC | 471,755 | $3,647,000 | 1.68% |
| Manatuck Hill Partners, LLC | 125,000 | $966,000 | 0.89% |
| Soleus Capital Management, L.P. | 69,600 | $538,000 | 0.63% |
| EAM Investors, LLC | 136,098 | $1,052,000 | 0.33% |
| Granahan Investment Management | 691,130 | $5,342,000 | 0.29% |
| EAM Global Investors LLC | 61,795 | $478,000 | 0.28% |
| Winning Points Advisors, LLC | 35,000 | $269,000 | 0.26% |
| Leap Investments LP | 14,200 | $110,000 | 0.16% |
| Avenir Corp | 150,600 | $1,164,000 | 0.16% |